Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512135
Status:
COMPLETED
Last Update Posted:
2021-04-02
First Post:
2007-08-06
Brief Title:
Safety and Efficacy of NT 201 IncobotulinumtoxinA Xeomin in the Treatment of Glabellar Frown Lines
Sponsor:
Merz Pharmaceuticals GmbH
Organization:
Merz Pharmaceuticals GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-06
First Submit QC Date:
August 6 2007
Study First Post Date:
2007-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-04-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-08
Last Update Post Date:
2021-04-02
Last Update Post Date Type:
ACTUAL